primary human pasmcs (ScienCell)
Structured Review
Primary Human Pasmcs, supplied by ScienCell, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+pasmcs/primary+human+pasmcs/pm40560058-360-4-10
Average 90 stars, based on 1 article reviews
Images
Related Articles
Cell Culture:Article Title: GRK2–YAP signaling is implicated in pulmonary arterial hypertension development Article Snippet: .. [22] Article Title: GRK2–YAP signaling is implicated in pulmonary arterial hypertension development Article Snippet: .. [ ] Article Title: The HIF‐1α/miR‐26a‐5p/PFKFB3/ULK1/2 axis regulates vascular remodeling in hypoxia‐induced pulmonary hypertension by modulation of autophagy Article Snippet: © 2023 Federation of American Societies for Experimental Biology.. Chaoqun Ma, Qiang Xu and Songqun Huang contributed equally to this work.. Abbreviations: AoSMCs, aortic smooth muscle cells; ATG5, autophagyrelated 5; AUC, area under the curve; CCK8, cell counting kit8; CHD, congenital heart disease; ChIP, chromatin immunoprecipitation; CQ, hydroxychloroquine; EdU, 5Ethynyl2′deoxyuridine; eIF2α, eukaryotic initiation factor 2α; F2,6BP, fructose2,6bisphosphate; FBS, fetal bovine serum; GFP, green fluorescent protein; H&E, hematoxylin and eosin; HCC, hepatocellular carcinoma; HIF1α, hypoxiainducible factor 1α; HRM, hypoxiarelated miRNA; IF, immunofluorescence; IHC, immunohistochemistry; ISH, in situ hybridization; LC3B, microtubuleassociated protein 1 light chain 3 beta (MAP1LC3B); LV, left ventricle; MCT, monocrotaline; miRNA, microRNA; mPAP, mean pulmonary arterial pressure; MUT, muted; p62, sequestosome 1 (SQSTM1); PAH, pulmonary arterial hypertension; PAHCHD, PAH associated with CHD; PASMC, pulmonary arterial smooth muscle cell; PCNA, proliferating cell nuclear antigen; PDGF, plateletderived growth factor; PFKFB3, 6phosphofructo2kinase/fructose2,6biphosphatase 3; postMI, postmyocardial infarction; pULK1, phosphorULK1; qRTPCR, quantitative reversetranscription polymerase chain reaction; ROC, receiver operating characteristic; RV, right ventricle; RVSP, right ventricular systolic pressure; S, septum; SD, standard deviation; SMA, smooth muscle actin; SMCGS, smooth muscle cell growth supplement; SMCM, smooth muscle cell medium; TIGAR, TP53induced glycolysis and apoptosis regulator; ULK1/2, unc51like autophagy activating kinase 1/2; WT, wild type. Article Title: Inhibition of immunoglobulin E attenuates pulmonary hypertension. Article Snippet: To prepare bone marrow mononuclear cells (BMMCs), bone marrow cells from C57BL/6 male mice were cultured in RPMI-1640 medium (Solarbio) for 5–6 weeks with 10 ng ml−1 of mouse recombinant IL-3 (PeproTech) and 10 ng ml−1 of stem cell factor (PeproTech)11. .. Incubation:Article Title: MicroRNA miR-627-5p restrains pulmonary artery smooth muscle cell dysfunction by targeting MAP 2 K4 and PI3K/AKT signaling. Article Snippet: .. |

![Excess BCAAs promoted a pro-ferroptotic phenotype in <t>human</t> <t>PASMC</t> . (A) Representative confocal micrographs of PASMC stained with MitoTracker Orange and quantification of mitochondrial organization in control and BCAA-treated PASMC (Control PASMC [Con]: 1.1±0.6, BCAA-Treated PASMC [BCAA]: 0.7±0.3); p -values determined by Mann-Whitney U-test. (B) Confocal micrographs of TRME-stained PASMC in control and BCAA-treated media, with corresponding quantification of mitochondrial membrane hyperpolarization, indicated by fluorescence intensity (Con: 8.3±17.2, BCAA: 42.7±9.7). p -values determined by Mann-Whitney U-test. (C) Excess BCAAs increase mitochondrial ROS, demonstrated by confocal micrographs of control and BCAA-treated PASMCs stained with MitoSox Red (Con: 6.4±2.1, BCAA: 14.5±6.9 MFI). p -values determined by Mann-Whitney U-test. (D) Representative confocal micrographs of control, BCAA-treated, and BCAA and ferrostatin-1-treated PASMCs incubated with 50 μM oleate and 50 μM palmitate and stained for lipid peroxidation using BODIPY (Con: 1.8±0.3, BCAA: 1.4±0.1, BCAA-treated with 5 μM ferrostatin-1 [BCAA-FER1]: 1.7±0.3). p -values determined by Kruskal-Wallis test and Dunn’s multiple comparisons test. (E) Incubation with BCAAs induces ferroptotic cell death, demonstrated by viability staining of control, BCAA-treated, and BCAA-treated with ferrostatin-1 PASMCs via Trypan Blue (Con: 9.4±7.5, BCAA: 31.7±11.7, BCAA-FER1: 13.0±11.1). White arrows indicate trypan blue-positive cells. p -values determined by ordinary one-way ANOVA with Tukey’s multiple comparison test.](https://bio-rxiv-images-cdn.bioz.com/dois_ending_with_19/10__1101_slash_2025__09__03__672819/10__1101_slash_2025__09__03__672819___F3.large.jpg)